News Focus
News Focus
Followers 15
Posts 1043
Boards Moderated 0
Alias Born 09/23/2020

Re: None

Friday, 05/12/2023 5:45:53 PM

Friday, May 12, 2023 5:45:53 PM

Post# of 196266
https://www.sec.gov/Archives/edgar/data/1402945/000149315223016738/ex99-1.htm

MIAMI, FL , May 12, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- ?Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology provider, today announced financial results for the first quarter ended March 31, 2023 . The Company experienced record quarterly revenues of $11.4 million , a 13% growth from the first quarter ended March 31, 2022 .
First Quarter 2023 Financial Highlights:
Total pharmacy revenue increased by $1.3 million , or 13%, to $11.4 million during the three months ended March 31, 2023 , compared to $10.1 million in the prior year period.
Prescription revenue increased by $1.8 million , or 21%, to $10.4 million during the first quarter of 2023, compared to $8.6 million in the prior year period, primarily reflecting an 8% year-over-year increase in the number of prescriptions filled period-over-period.
340B contract revenue was $1.6 million during the first quarter of 2023, an increase of $1.2 million , compared to $0.4 million in the prior year period. The increase was primarily attributable to an increase in our existing 340B contracts of approximately $0.9 million and an increase in new 340B contract revenue of approximately $0.3 million .
Gross profit margin increased from 24% for the three months ended March 31, 2022 , to 28% for the three months ended March 31, 2023 , primarily due to the increase in 340B contract revenue, which has higher margins than revenue generated from pharmacy operations.
Cash balance as of March 31, 2023 was approximately $7.5 million as compared to $6.7 million at December 31, 2022 , a $0.8 million increase
Organizational Highlights and Recent Business Developments
On May 1, 2023 , the Company appointed Dr. Pamela Roberts as Chief Operating Officer. Dr. Roberts formerly served as the Company’s Director of Pharmacy and Pharmacist in Charge.
On May 9, 2023 , the Company successfully completed a transaction of $1.0 million investment from NextPlat Corp.


My comments and implied views are provided for entertainment purposes. I am not a certified financial advisor, and I am not qualified to give financial advice. Please do your own due diligence and make your own decisions.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today